Abstract
The pathophysiology of Alzheimer's disease (AD) involves the deposition of amyloid in the brain and the extensive loss of neurons. The mechanisms subserving neuronal death in the disease remain unclear, although it has been postulated that this is due to apoptosis. There is compelling evidence that inflammatory processes play a role in disease progression and pathology. Amyloid plaque deposition is accompanied by the association of microglia with the senile plaque, and this interaction stimulates these cells to undergo phenotypic activation and the subsequent elaboration of proinflammatory and neurotoxic products. This review focuses on the mechanisms by which neurons are lost in AD and the role microglial proinflammatory products play in neuronal death.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
-
Review
MeSH terms
-
Alzheimer Disease / metabolism
-
Alzheimer Disease / pathology*
-
Alzheimer Disease / physiopathology*
-
Alzheimer Disease / prevention & control
-
Amyloid beta-Peptides / immunology*
-
Amyloid beta-Peptides / metabolism
-
Animals
-
Antibodies / administration & dosage
-
Apoptosis*
-
Cytoskeletal Proteins / metabolism
-
Humans
-
Inflammation* / physiopathology
-
Membrane Proteins / metabolism
-
Microglia / metabolism
-
Microglia / pathology
-
Neurofibrillary Tangles / pathology
-
Plaque, Amyloid / pathology
-
Presenilin-1
-
Presenilin-2
-
Trans-Activators / metabolism
-
Vaccines / administration & dosage
-
beta Catenin
Substances
-
Amyloid beta-Peptides
-
Antibodies
-
CTNNB1 protein, human
-
Cytoskeletal Proteins
-
Membrane Proteins
-
PSEN1 protein, human
-
PSEN2 protein, human
-
Presenilin-1
-
Presenilin-2
-
Trans-Activators
-
Vaccines
-
beta Catenin